Towards Healthcare
Nuclear Medicine Software Market to Increase USD 2109.19 Mn by 2034

Nuclear Medicine Software Market North America Leads, Asia-Pacific Rising, AI Diagnostics Driving the Future

Projections indicate that, the global nuclear medicine software market will increase from USD 895.04 million in 2024 to USD 2109.19 million by 2034, experiencing a CAGR of 8.95% over the next 10 years.The global market is fueled by continuous collaborations, initiatives, and advancements in imaging technologies. The major involvement in healthcare infrastructure and advanced techniques is driving North America’s market.

  • Insight Code: 6006
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The nuclear medicine software market holds a valuation of USD 975.15 million as of 2025, and will expand to USD 2109.19 million by 2034, achieving a CAGR of 8.95% between 2024 and 2034.

North America is currently leading the nuclear medicine software market due to advancing healthcare systems with the adoption of imaging technologies.

The nuclear medicine software market includes 5 segments such as by modality imaging type, by functionality capabilities, by deployment mode, by end-user, and by region.

Key trends include the increasing demand for early disease detection and precision treatment, growth in the healthcare infrastructure, and innovation in imaging technologies and software.

The clinical applications of nuclear medicine include diagnosing and treating different conditions, such as thyroid disorders, cancers (like lymphomas and thyroid cancer), and bone pain. 

AERB, NIBIB, NCI, US FDA, NIST, IAEA, PIB, ESIC, CMS, ACTREC, etc.